Nanite Receives Funding to Employ SAYERTM Platform to Develop Non-Viral Delivery Vehicles to Express Neutralizing Antibodies In Vivo from the Bill & Melinda Gates Foundation BOSTON, May 8, 2024 /PRNewswire/ — Nanite, Inc. today announced a $1.8M grant from...
Graphical abstract. Credit: Journal of Controlled Release (2024). DOI: 10.1016/j.jconrel.2023.12.043 Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the...
Dr. Nadia Amrani, a scientist at Excision Biotherapeutics conducts pre-clinical tissue culture studies testing Excision’s dual-guide CRISPR strategies for viral excision as part of the company’s efforts to develop a cure for HIV. (Photo Credit: Dawn...
